The DOI matches its Crossref record.
Preface
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
All three acetylcholinesterase inhibitor drugs delay neurodegeneration and stabilise cognition when used in patients with mild to severe Alzheimer's disease symptoms, as shown in clinical trials.
“All three drugs delay neurodegeneration and stabilise cognition when used in patients with mild to severe AD symptoms, as shown in clinical trials.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [35]
Between 5 and 20% of patients treated with acetylcholinesterase inhibitors show adverse effects mainly associated with the digestive, cardiac, and pulmonary systems.
“reports indicate that between 5 and 20% of patients show adverse effects mainly associated with the digestive, cardiac and pulmonary systems”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [35]
Memantine is normally well-tolerated without the gastrointestinal adverse effects presented by acetylcholinesterase inhibitors, but some patients manifest dizziness, constipation, headache, cough, and drowsiness.
“It is normally well-tolerated without the adverse effects presented by the AChEI at the gastrointestinal level, which are the most severe; however, some patients have manifested negative effects such as dizziness, constipation, headache, cough, and drowsiness [33,35,36].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [35]
Citations
Cited by
Sorted by citations
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125
Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
Pádua, M. S., Guil-Guerrero, J. L., Prates, J. A. M., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052805 · Cited by 46
Iqbal, D., Alsaweed, M., Jamal, Q. M. S., Asad, M. R., Rizvi, S. M. D., Rizvi, M. R., Albadrani, H. M., Hamed, M., Jahan, S., & Alyenbaawi, H. (2023) · Biomolecules · doi:10.3390/biom13111613 · Cited by 50
Marine-Derived Components: Can They Be a Potential Therapeutic Approach to Parkinson’s Disease?
Silva, J., Alves, C., Soledade, F., Martins, A., Pintéus, S., Gaspar, H., Alfonso, A., & Pedrosa, R. (2023) · Marine Drugs · doi:10.3390/md21080451 · Cited by 35
Iqbal, D., Rehman, M. T., Alajmi, M. F., Alsaweed, M., Jamal, Q. M. S., Alasiry, S. M., Albaker, A. B., Hamed, M., Kamal, M., & Albadrani, H. M. (2023) · Pharmaceuticals · doi:10.3390/ph16040622 · Cited by 25
Novel NMDA-receptor antagonists ameliorate vanadium neurotoxicity
Ladagu, A. D., Olopade, F. E., Folarin, O. R., Elufioye, T. O., Wallach, J. V., Dybek, M. B., Olopade, J. O., & Adejare, A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01882-6 · Cited by 12
Self-citationStochastic Modeling and Simulation of Filament Aggregation in Alzheimer’s Disease
Ojha, V. P., Yarahmadian, S., & Om, M. (2024) · Processes · doi:10.3390/pr12010157 · Cited by 5
Metadata
- Authors
- Adejare, A.
- Affiliations
- University of the Sciences (US)
- Corresponding author
- Adejare, Adeboye
- ORCID
- Adejare, Adeboye
- Venue
- Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
- Publisher
- Elsevier
- Published
- 2017
- Pages
- xv-xvi
- OpenAlex
- W4239160156
- Cited by
- 7
- References
- 0
- Citations by year
- 2024: 2 · 2023: 3 · 2022: 1 · 2020: 1
- Type
- paratext
- Language
- en
- Open access
- closed
- Locations
- Elsevier eBooks (publishedVersion)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
